Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-02-13
1999-05-18
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514307, 514308, 514343, 514355, 514356, 514610, 514611, A01N43/42
Patent
active
059050861
DESCRIPTION:
BRIEF SUMMARY
TECHNICAL FIELD
This invention relates to remedies for anxiety neurosis, in particular, drugs efficacious in treating panic disorder characterized by containing N-(2-hydroxyethyl)nicotinamide nitrate or its salt as the active ingredient.
BACKGROUND ART
Anxiety neurosis means neurosis in a broad sense with anxiety being the predominant symptom. According to DSM-III edited by U.S. Society of Psychiatry in 1980, anxiety neurosis is classified into panic disorder and global anxiety neurosis.
It has been a practice to treat anxiety neurosis including panic disorder with the use of tricyclic antidepressive drugs or benzodiazepine anxiolytic drugs. However, it is pointed out that these drugs suffer from some problems. Namely, the tricyclic antidepressive drugs exert their effects slowly and give rise to cholinolytic side effects. On the other hand, the benzodiazepine anxiolytic drugs induce side effects of hypersedation, break-off phenomenon, etc. and, moreover, produce addiction. That is to say, there has been known no satisfactory remedy for anxiety neurosis.
On the other hand, N-(2-hydroxyethyl)nicotinamide nitrate (generic name: nicorandil) is a known compound which has been marketed as a remedy for angina pectoris and described in, for example, Japanese Patent Publication (Kokai) No. 52-122373. It is known that nicorandil has several effects in addition to the antianginal effect. For example, Japanese Patent Publication (Kokai) No. 53-9323 states that it is efficacious as a remedy for circulatory diseases, while Japanese Patent Publication (Kokai) No. 58-85819 points out its bronchodilating effect. Furthermore, Japanese Patent Publication (Kokai) No. 63-152317 discloses that nicorandil is useful as a remedy for diseases accompanied by cerebral ischemic lesion and Japanese Patent Publication (Kokai) No. 3-101621 indicates that it is useful as a hydroxyl radical scavenger. However, it has not been known that nicorandil and its analogs are useful in the treatment of anxiety neurosis, in particular, panic disorder.
As described above, the tricyclic antidepressive drugs conventionally employed in the treatment of anxiety neurosis, in particular, panic disorder exert their effects slowly and suffer from problems of giving rise to cholinolytic side effects (thirst, constipation, urinary difficulty, etc.) and other serious side effects. On the other hand, it is known that the benzodiazepine anxiolytic drugs induce side effects of hypersedation, break-off phenomenon, drug-addiction, muscle relaxation, etc. Thus, it has been urgently required to develop highly safe drugs by which panic disorder or the following anxiety can be prevented or ameliorated.
DISCLOSURE OF THE INVENTION
Under these circumstances, the present inventors have conducted extensive studies to develop drugs which are efficacious against anxiety neurosis, in particular, panic disorder and exert few side effects. As a result, they have found that N-(2-hydroxyethyl)nicotinamide nitrate or its salt is useful in preventing not only anxiety neurosis but also the following anxiety, thus completing the present invention.
BEST MODE FOR CARRYING OUT THE INVENTION
N-(2-Hydroxyethyl)nicotinamide nitrate (generic name: nicorandil) to be used as the active ingredient in the present invention is a compound which has been marketed as a remedy for angina pectoris. It is possible in the present invention to use marketed nicorandil tablets or injections as such. Alternatively, use may be made therefor of those prepared by, for example, the method described in Japanese Patent Publication (Kokai) No. 52-122373.
Nicorandil to be used as the active ingredient in the present invention may form acid-addition salts together with pharmaceutically acceptable organic or inorganic acids. These salts are also usable in the present invention. Examples of the acid-addition salts include hydrochloride, hydrobromide, phosphate, sulfate, nitrate, oxalate, lactate, tartrate, acetate, salicylate, benzoate, formate, propionate, pivalate, diethylacetate, malonate, succinate, pim
REFERENCES:
patent: 5428039 (1995-06-01), Cohen
Endoh et al., Tohoku J. Exp. Med., vol. 130, pp. 199-201, 1980.
Inoue et al., J. Pharmacol. Exp. Ther., vol. 299, No. 3, pp. 793-802, 1984.
Chugai Seiyaku Kabushiki Kaisha
Mohamed Abdel A.
Tsang Cecilia J.
LandOfFree
Remedy for anxiety neurosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Remedy for anxiety neurosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remedy for anxiety neurosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1759659